Filing metadata

Accession number
0001415889-24-022702
Form type
Form 4
Filer
Quince Therapeutics, Inc.
CIK
CIK 1662774
Filed
Sep 03, 2024
Reporting period
Aug 29, 2024
Description
Insider transaction

Explore SEC Filings Hub